Published in Assay Drug Dev Technol on August 01, 2013
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun (1991) 15.39
Bacterial quorum-sensing network architectures. Annu Rev Genet (2009) 6.14
Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A (2002) 6.10
Parallel quorum sensing systems converge to regulate virulence in Vibrio cholerae. Cell (2002) 5.12
Carbon catabolite repression in bacteria: choice of the carbon source and autoregulatory limitation of sugar utilization. FEMS Microbiol Lett (2002) 2.67
Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae. Proc Natl Acad Sci U S A (1997) 2.58
Allosteric regulation of the cAMP receptor protein. Biochim Biophys Acta (2001) 2.19
Overlapping binding sites for the virulence gene regulators AphA, AphB and cAMP-CRP at the Vibrio cholerae tcpPH promoter. Mol Microbiol (2001) 1.94
The cyclic AMP receptor protein modulates quorum sensing, motility and multiple genes that affect intestinal colonization in Vibrio cholerae. Microbiology (2007) 1.69
Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther (2000) 1.64
Analogs of cyclic AMP that elicit the biochemically defined conformational change in catabolite gene activator protein (CAP) but do not stimulate binding to DNA. J Mol Biol (1985) 1.55
Evolution of allostery in the cyclic nucleotide binding module. Genome Biol (2007) 1.44
Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios. PLoS Pathog (2012) 1.11
MetR and CRP bind to the Vibrio harveyi lux promoters and regulate luminescence. Mol Microbiol (2002) 1.00
Determination of the conformations of cAMP receptor protein and its T127L,S128A mutant with and without cAMP from small angle neutron scattering measurements. J Biol Chem (1998) 0.97
Investigations on stimulation of lac transcription in vivo in Escherichia coli by cAMP analogues. Biological activities and structure-activity correlations. Eur J Biochem (1984) 0.95
Cyclic AMP-dependent functional forms of cyclic AMP receptor protein from Vibrio cholerae. Arch Biochem Biophys (2006) 0.82
High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) (2009) 2.58
Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis (Edinb) (2009) 1.94
The cyclic AMP receptor protein modulates quorum sensing, motility and multiple genes that affect intestinal colonization in Vibrio cholerae. Microbiology (2007) 1.69
A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Res (2006) 1.50
Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol (2009) 1.44
Transcriptional regulation of Vibrio cholerae hemagglutinin/protease by the cyclic AMP receptor protein and RpoS. J Bacteriol (2004) 1.41
Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology (2003) 1.38
High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv. Tuberculosis (Edinb) (2011) 1.23
Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J Biomol Screen (2006) 1.18
Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera. Infect Immun (2006) 1.18
Polyphosphate stores enhance the ability of Vibrio cholerae to overcome environmental stresses in a low-phosphate environment. Appl Environ Microbiol (2006) 1.16
High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2). J Biomol Screen (2008) 1.15
A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase. J Biomol Screen (2006) 1.14
The cyclic AMP receptor protein modulates colonial morphology in Vibrio cholerae. Appl Environ Microbiol (2007) 1.13
Role of the histone-like nucleoid structuring protein in the regulation of rpoS and RpoS-dependent genes in Vibrio cholerae. J Bacteriol (2008) 1.09
Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen. J Biomol Screen (2010) 0.97
Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Res (2009) 0.96
Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors. Bioorg Med Chem (2011) 0.95
Adapting Cell-Based Assays to the High Throughput Screening Platform: Problems Encountered and Lessons Learned. JALA Charlottesv Va (2008) 0.94
Interaction of the histone-like nucleoid structuring protein and the general stress response regulator RpoS at Vibrio cholerae promoters that regulate motility and hemagglutinin/protease expression. J Bacteriol (2011) 0.93
Exercise-induced pain requires NMDA receptor activation in the medullary raphe nuclei. Med Sci Sports Exerc (2012) 0.92
The PhoB regulatory system modulates biofilm formation and stress response in El Tor biotype Vibrio cholerae. FEMS Microbiol Lett (2009) 0.92
A Vibrio cholerae relaxed (relA) mutant expresses major virulence factors, exhibits biofilm formation and motility, and colonizes the suckling mouse intestine. J Bacteriol (2006) 0.92
High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity. J Biomol Screen (2011) 0.91
HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity. Molecules (2010) 0.91
Interplay among cyclic diguanylate, HapR, and the general stress response regulator (RpoS) in the regulation of Vibrio cholerae hemagglutinin/protease. J Bacteriol (2011) 0.90
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus. J Med Chem (2014) 0.89
Induction of interleukin-8 in T84 cells by Vibrio cholerae. Infect Immun (2004) 0.89
Cyclic AMP post-transcriptionally regulates the biosynthesis of a major bacterial autoinducer to modulate the cell density required to activate quorum sensing. FEBS Lett (2008) 0.88
Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. Bioorg Med Chem (2008) 0.88
A high-throughput screening assay for inhibitors of bacterial motility identifies a novel inhibitor of the Na+-driven flagellar motor and virulence gene expression in Vibrio cholerae. Antimicrob Agents Chemother (2011) 0.87
The histone-like nucleoid structuring protein (H-NS) is a repressor of Vibrio cholerae exopolysaccharide biosynthesis (vps) genes. Appl Environ Microbiol (2012) 0.86
(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection. J Med Chem (2012) 0.86
A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus. Virol J (2013) 0.85
Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening. J Neurosci Res (2011) 0.83
A high-throughput screening strategy to overcome virus instability. Assay Drug Dev Technol (2010) 0.82
The LuxR-type regulator VpsT negatively controls the transcription of rpoS, encoding the general stress response regulator, in Vibrio cholerae biofilms. J Bacteriol (2013) 0.81
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. J Biomol Screen (2011) 0.81
Primary and secondary drug screening assays for Friedreich ataxia. J Biomol Screen (2011) 0.80
High-throughput RNA interference screening: tricks of the trade. J Lab Autom (2013) 0.80
Exercise prevents development of autonomic dysregulation and hyperalgesia in a mouse model of chronic muscle pain. Pain (2016) 0.79
A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus. Assay Drug Dev Technol (2014) 0.79
Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity. J Med Chem (2014) 0.79
Differential response of Vibrio cholerae planktonic and biofilm cells to autoinducer 2 deficiency. Microbiol Immunol (2009) 0.79
Exploiting cholera vaccines as a versatile antigen delivery platform. Biotechnol Lett (2007) 0.79
Screening methods for influenza antiviral drug discovery. Expert Opin Drug Discov (2012) 0.79
The NIH's role in accelerating translational sciences. Nat Biotechnol (2012) 0.79
A high-throughput screen for chemical inhibitors of exocytic transport in yeast. Chembiochem (2010) 0.78
Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis. Vaccine (2003) 0.77
Expression of foreign proteins in a Vibrio cholerae vaccine strain using the stationary phase hemagglutinin/protease promoter. Biotechnol Lett (2007) 0.76
A quinazoline-2,4-diamino analog suppresses Vibrio cholerae flagellar motility by interacting with motor protein PomB and induces envelope stress. Antimicrob Agents Chemother (2013) 0.76
Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae. FEMS Immunol Med Microbiol (2005) 0.76
Attenuation of bacterial virulence by quorum sensing-regulated lysis. J Biotechnol (2010) 0.75
Polymerization of C-terminally truncated Mycobacterium tuberculosis FtsZ is unlikely to be physiologically relevant. Microbiology (2004) 0.75
Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay Drug Dev Technol (2015) 0.75
NIH: translation centre bridges a gap. Nature (2011) 0.75
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. bioRxiv (2020) 0.75
Development of multiplex DNA electronic microarrays using a universal adaptor system for detection of single nucleotide polymorphisms. Biotechniques (2004) 0.75